Mechanism of action and spectrum of cell lines sensitive to a doxorubicin-transferrin conjugate

Cancer Chemotherapy and Pharmacology

Volumn 41, Issue 2, 1997, Pages 155-160

  Lai, Bai Tang ^a,b   Gao, Jian Ping ^a   Lanks, Karl W ^a  

^a STATEN ISLAND UNIVERSITY HOSPITAL   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Adriamycin; Doxorubicin resistance; Drug resistance; Free radicals

Indexed keywords

DOXORUBICIN; FREE RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TRANSFERRIN; TRANSFERRIN RECEPTOR;

ANIMAL CELL; ARTICLE; BLADDER CARCINOMA; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL STRAIN L 929; CYTOTOXICITY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG MECHANISM; FLUORESCENCE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031881834     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050722     Document Type: Article

References (11)

1. Diener E, Diner UE, Sinha A, Xie S, Verdigis R (1986) Specific immunosuppression by immunotoxins containing daunomycin. Science 231: 148
2. Hatano T, Ohkawa K, Matsuda M (1993) Cytotoxic effect of the protein-doxorubicin conjugates on the multidrug-resistant human myelogenous leukemia cell line, K562, in vitro. Tumor Biol 14: 288
3. Gabor F, Wollmann K, Theyer G, Haberl I, Hamilton G (1994) In vitro antiproliferative effects of albumin-doxorubicin conjugates against Ewing's sarcoma and peripheral neuroectodermal tumor cells. Anticancer Res 14: 1943
4. Berczi A, Barabas K, Sizensky JA, Faulk WP (1993) Adriamycin conjugates of human transferrin bind transferrin receptors and kill K562 and HL60 cells. Arch Biochem Biophys 300: 356
5. Fritzer M, Barabas K, Szuts V, Berczi A, Szekeres T, Faulk WP, Goldenberg H (1992) Cytotoxicity of a transferring adriamycin conjugate to anthracycline-resistant cells. Int J Cancer 52: 619
6. Faulk WP, Taylor CG, Yeh CG, McIntyre JA (1990) Preliminary study of transferrin-adriamycin conjugate for drug delivery to acute leukemia patients. Mol Biother 2: 57
7. Thorstensen K, Romslo I (1993) The transferrin receptor: its diagnostic value and its potential as therapeutic target. Scand J Clin Lab Invest 53 [Suppl 215]: 113
8. Lanks KW, Gao JP, Sharma T (1994) Photodynamic enhancement of doxorubicin cytotoxicity. Cancer Chemother Pharmacol 35: 17
9. Ohkawa K, Hatano T, Tsukada Y, Matsuda M (1993) Chemotherapeutic efficacy of the protetn-doxorubicin conjugates on multidrug resistant rat hepatoma cell line in vitro. Br J Cancer 67: 274
10. Barabas K, Sizensky JA, Faulk WP (1992) Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA. J Biol Chem 267: 9437
11. Gao JP, Friedman S, Lanks KW (1993) The role of reduced nicotinamide adenine dinucleotide phosphate in glucose- and temperature-dependent doxorubicin cytotoxicity. Cancer Chemother Pharmacol 33: 191